Haim Pharma Group Ltd.
General Data
Reg Number
516598612
Sector
Biomed
Established
2022
No. of Employees
2
Stage
R&D
Additional Funding
0
Technology
Pharmaceutical.
Targeted Customers
Neurodegenerative Disease Market, focus on Amyotrophic lateral sclerosis (ALS)/Motor Neuron Disease (MND) and Parkinson's Disease.
Management personnel
Miriam O'Reilly - CEO & Founder
Winning details
Route name
Winning year
Increasing participation of Israeli industrial corporations in the European Horizon program
Increasing participation of Israeli industrial corporations in the European Horizon program
2023
Ideation (Tnufa) Incentive Program – Startup Fund
Ideation (Tnufa) Incentive Program – Startup Fund
2025